Treating Depression in Children and Adolescents With Chronic Physical Illness



Treating Depression in Children and Adolescents With Chronic Physical Illness


ROBERTO ORTIZ-AGUAYO

JOHN V. CAMPO





Depressive disorders are chronic illnesses in their own right and carry significant disability. The World Health Organization has estimated depression to be the fourth leading cause of disease burden in 2000, and it is expected to become the second leading cause of global disease burden by 2020, behind heart disease; moreover, the impact of depression on overall health and well-being is greatest when depression is comorbid with chronic physical disease.6 Rather than being just another disorder suffered by a physically ill child, the relationship between physical disease and depression is often complex and bidirectional.

Physical disorders can be an independent risk, etiologic, or perpetuating factor for depression, and some disorders such as migraine and the tendency to develop allergic diseases may share genetic vulnerability with depression.7,8 Children with chronic physical illness have been found to be at greater risk of syndromal and subsyndromal depression in comparison with healthy peers, with risk being highest when the physical illness affects the central nervous system.9,10,11 Disease-modifying relationships between depressive syndromes and chronic physical illness are many and, in the vast majority of cases and across disease categories, multifactorial.

Conversely, psychiatric disorders may negatively impact the onset and course of physical disease. First, depression may increase the likelihood of nonadherence to prescribed treatments12,13 and interfere with a healthy lifestyle. Second, depression in physically ill youth is associated with greater health care usage and cost, less optimal medical outcomes, worsening metabolic markers of disease control, worsening functional impairment, lower scores in quality of life measures, and increased mortality.14,15,16,17 Third, depression may also affect the physiology of the disease process itself.16 For example, diabetic children are at elevated risk to develop depression,18 which increases the risk of nonadherence to treatment, repeat hospitalization, and of disease-related complications such as diabetic retinopathy.19 It follows that aggressively treating depressive illness in physically ill youth may not only relieve depression-related suffering and impairment but may also benefit the management of the comorbid physical disease.

Unfortunately, data on the treatment of depression in chronically ill children are limited, largely because randomized controlled trials (RCTs) have typically excluded physically ill youth. The aim of this chapter is to highlight what is currently known about the treatment of depression in children and adolescents with chronic physical illness and offering practical clinical guidance based on cumulative clinical experience, case reports and case series, and available studies. In the absence of
data from systematic and representative RCTs, clinicians must weigh the evidence carefully and in the context of each individual case when making diagnostic and treatment decisions. Frank discussion of existing limitations to the evidence base with patients and families as well as with professional colleagues is imperative in the spirit of true informed consent and practice (see Chapter 4). Child and children are used to mean both children and adolescents unless specified otherwise.


ASSESSMENT AND DIAGNOSIS

As highlighted in Chapter 3 and other parts of this book, an accurate diagnosis should precede treatment and provide information about illness course, prognosis, and treatment, as well as facilitating clinical and research communication. Pediatric depressive disorders have been well validated as a diagnostic entity, and a diagnosis of depression in childhood has clear prognostic implications.20 Given the complex relationship between depression and physical disease, a careful assessment is critical. The clinician must appreciate how physical disease and its treatment impact on mood, and remain alert to how mood and mood disorder may impact on chronic physical illness.

The differential diagnosis of depressive syndromes in children with chronic physical illness is broad and includes, but is not limited to, primary mood disorders (e.g., major depressive disorder, dysthymic disorder, bipolar disorder), transient reactions to stressors (e.g., adjustment disorders, bereavement), and mood disorders secondary to a general medical condition or its treatment (e.g., nutritional deficiency, left-sided stroke, tacrolimus, or steroid immunosuppression) (see also Table 1.4). Specific diagnostic criteria for each have been described in Chapters 1, 3, and elsewhere.21,22 Depressive disorders are also frequently comorbid with other psychiatric disorders in physically ill youth, including anxiety disorders and posttraumatic stress disorder. In circumstances where there is considerable impairment, yet uncertainty about the specific diagnosis remains, it may be possible to identify circumscribed symptoms that are amenable to intervention.

Clinicians face numerous challenges in the evaluation and diagnosis of depression in chronically ill children. An integrative approach is recommended, with particular emphasis on the evaluation of changes in functioning from baseline and across domains. Consequently, clinicians working with chronically ill youth need to gather information from multiple sources and coordinate care with parents, other medical professionals, family, social agencies, schools, and relevant community systems. The taxing consequences of the child’s chronic physical illness for the child and family should be assessed and relevant findings incorporated into treatment planning. Attention should be paid to peer interactions and developmental tasks that are disrupted by the illness, its timing, or its effects on physical appearance, sexual identity and development, and functional status. Individual, developmental, family, and cultural health beliefs and the quality of communication between the family, patient, and medical care providers should be assessed and included as relevant to the biopsychosocial formulation and as potential targets for intervention. Possible medicolegal issues and the role of health-care systems should also be explored. The possibility that the child’s depressive symptoms may be explained, wholly or in part, by the comorbid physical disease should always be considered and the current and past medical history should be carefully reviewed. Current and recently prescribed medications should be determined, including the use of contraceptives, vitamins, dietary supplements, and herbal remedies. The clinician should consult the package insert, Internet resources, the pharmacy service, and the Medical Letter regarding potential psychiatric effects of current medications. It should be always kept in mind the possibility that a female patient may be pregnant. The possibility that a female patient may be pregnant should always be kept in mind.

Much has been written about the challenges associated with diagnosing depressive disorders in the physically ill, with both under- and overdiagnosis generating concern. Underrecognition reduces the number of youth capable of experiencing symptomatic relief and functional improvement, whereas overdiagnosis may be associated with the risk of stigmatizing a particular child or exposing him or her to needless or overly aggressive treatment. The risk of misattributing symptoms of the chronic physical disease (e.g., fatigue or poor sleep or appetite) to a mood disorder has been a topic of much discussion. Attributing a symptom such as fatigue to either the physical disease or to depression is highly subjective and thus notoriously unreliable. Similarly, dysphoria in the context of chronic physical illness must also be assessed, and a sympathetic adult can easily “explain away” associated emotional distress as situational and an adjustment to the existing physical health problem.


Although differentiating the consequences of traditional physical disease from depression is challenging, the existing social context and the stigma associated with a diagnosis of mental disorder and psychiatric treatment appear to mitigate the likelihood of reckless overdiagnosis of depression in chronically ill youth. Stigma can be a powerful and often subliminal motivation to consider subjective and somatic symptoms of depression as only a consequence of the physical disease and thus “nothing to be ashamed of.” Well-meaning professionals may also wish to spare any additional “insult” to an already suffering child and family. It can thus be tempting for patients, families, and professionals to dismiss signs and symptoms of depression as a part of a “normal” or “justifiable” response to the underlying chronic illness. Biases in favor of or against the diagnosis of psychiatric disorder in the physically ill child have real consequences. Inadvertently creating a higher standard to diagnose depression in the physically ill results in underdiagnosis, and it places patients at further risk of physical and emotional decompensation owing to lack of treatment.

Because existing evidence suggests that most depressed children and adolescents are either unrecognized or inadequately treated, we recommend an inclusive approach to the diagnosis that considers all symptoms of depression elicited during examination as relevant regardless of whether physical illness could be responsible or not.23 This approach requires clinicians to address all potential sources of the patient’s subjective distress and impairment, and to initiate treatment based on a thoughtful evaluation of the risks and benefits in collaboration with the patient and family. Clinicians should carry out necessary laboratory investigations and request subspecialty consultation as guided by findings in the history and physical examination. Careful review of medications, with close attention to temporal relationships between psychiatric symptoms and the timing of medication initiation, discontinuation, and dosing change can be an invaluable part of the assessment. In our experience, by considering all symptoms of depression noted on examination to be relevant to the diagnosis of depression, the inclusive approach increases the sensitivity of clinicians to depression in the physically ill and is likely to be more reliable than one relying on the subjective judgment of clinicians in determining whether a particular symptom is “physical” or “mental.”


TREATMENT

As described in earlier chapters, clinical research has documented the efficacy of several interventions for pediatric depression,24 including psychotherapeutic treatments such as cognitive behavior therapy (CBT) (see Chapter 8) and interpersonal psychotherapy (IPT) (see Chapter 9), and pharmacologic treatment with antidepressants, most notably SSRIs25,26 (see Chapter 6). Despite a lack of large RCTs addressing the treatment of depression in physically ill youth, there is no evidence that depressed youth with comorbid physical illness are less likely to respond to proven treatments than their physically healthy counterparts. It is somewhat reassuring that depressed adults with chronic physical illness appear to respond to treatment at levels comparable with those of healthy adults.27 Consequently, active treatment consistent with the safe and effective management of depression in physically healthy children should be pursued in youth struggling with comorbid physical disease.


EDUCATION

It can be argued that the first and most important step in treatment involves creating informed consumers of care by a thoughtful discussion with the patient and family of assessment findings, diagnostic formulation, and their implications. Even in situations of relative uncertainty, patients and families benefit from working with the clinician to arrive at a shared working hypothesis regarding the patient’s difficulties. Psychoeducation is included in treatment guidelines25 and is critical to meaningful informed consent. Relevant issues to address include rationale for treatment and targets, potential benefits and risks of specific treatment alternatives, expected response, time to efficacy, and follow-up plans and expectations, including safety planning and criteria to seek emergency care. The clinician should also learn more about the child’s physical health condition and its management because this understanding is critical to establishing credibility and delivering quality care.

Psychoeducation is especially important because patients and families are often unaware of the impact that depression can have on the course and management of the comorbid physical disorder (i.e., that depression can have negative implications for the child’s physical health). Many pediatric
professionals view depression solely as a reaction to the stress of living with an acute or chronic physical disorder and an analogue to grief associated with the loss of ideal physical health. Although there is no doubt that depressive disorders may be triggered by adverse life events, some individuals are especially vulnerable to develop depression in response to negative life events.28 It is often helpful for patients and referring clinicians to understand that the diagnosis of a depressive disorder may reflect a vulnerability to suffer from depression on a chronic and recurrent basis, analogous to physical disorders such as asthma. Highlighting that the risk of recurrence is high can shed light on the seriousness of depression as a distinct entity regardless of the physical disease status.20 Depression cannot be dismissed as a onetime reactive event in the life of a child with chronic physical illness. There is no reason to believe that depressed youth with chronic illness are any less at risk for negative outcomes and recurrence than those without comorbid physical disease. Evaluation of this understanding may prevent miscommunication and unrealistic expectations that could become obstacles to treatment or sources of distress to patients and caregivers. Psychoeducation, supportive management, and family and school involvement should remain important across each phase of the treatment.

Patients and families need to understand what is known about available treatments, which often involves sharing our uncertainty with regard to treatment of depression in the context of a comorbid physical disease. In addition to understanding the risks and benefits, potential interventions should also be understood with regard to their cost to the family, not only financially, but in terms of time, effort, and overall burden (see Chapter 4). Clinicians should seek out and respect patient and family preferences while providing the information necessary for an informed choice. In particular, clinicians need to be clear about harmful options and should not agree to such treatment regardless of patient and family preference.


NONSOMATIC TREATMENTS

Psychotherapeutic interventions (see Chapters 8 to 11) are particularly appealing and often well received in the physically ill,29 where the use of antidepressant medications can pose special challenges (see later). Nevertheless, psychotherapeutic treatments present their own difficulties, with the most troublesome being the relative lack of access to qualified therapists. The time commitment necessary for travel and participation in regularly scheduled sessions can be burdensome to families already taxed by the demands of caring for a child with a chronic physical illness.

Several psychotherapeutic approaches have been described, most often anecdotally. Psychodynamic and family systems therapies have been helpful in exploring the patient’s and the family’s understanding of the illness and its prognosis, health beliefs, treatment and adherence, and relationships among family members and with professionals. Although without empirical support, play therapy interventions have been suggested as ways to offer developmentally sound access to emotional information in younger children and assist with education about the illness, treatment, and associated stressors. Positive effects on coping and resiliency have been reported in association with construction of a narrative explanation of the child and family’s illness experience.30,31 Structured therapies such as IPT have been applied to adjustment to the psychosocial challenges imposed by the illness process.32 Similarly, CBT focuses on the structured development of critical analysis skills, restructuring of maladaptive thought patterns, improvement of social and problem-solving skills, and the promotion of active coping.25 A small study of children suffering from depression and inflammatory bowel disease documented improvements in measures of depression, global adjustment, and physical functioning with CBT.33 Another small trial found CBT to be superior to treatment as usual for youth with inflammatory bowel disease and subsyndromal depression.34 Although relatively small, these studies show that chronic physical illness need not preclude the efficacy of CBT.

Other psychotherapeutic interventions have been used but have not been specifically tested in the management of depression per se. These include target-specific behavioral plans to improve adherence and extinguish maladaptive behaviors,35 self-management strategies such as relaxation training; guided imagery; biofeedback; and hypnosis, and distraction approaches using video games.36 Group therapy and the use of social service and community support resources may be invaluable to patients and families by encouraging the development of support networks, ongoing learning and coping through modeling and sharing of experiences, and by providing access to resources (e.g., financial, legal-advocacy, respite, medical foster care).



SOMATIC TREATMENTS


GENERAL CONSIDERATIONS

Psychopharmacologic treatment is practically and culturally well suited to the management of depression in medical settings, yet it presents special challenges given the increased likelihood of medication-related adverse events and both pharmacodynamic and pharmacokinetic drug interactions (see Chapter 14). Clinicians, patients, and families must realize that risk is more difficult to gauge when psychoactive medications are used in physically ill children. Because RCTs of antidepressants in physically ill children are lacking, such treatment is largely presumptive and frequently off-label (see Chapter 4). Accordingly, treatment must be individualized, carefully considering the risk of drug–disease and drug–drug interactions, and reviewing prescribing information in light of the patient’s physical illness and other medications. Table 21.1 lists a number of simple generic measures that can reduce the likelihood of medication-related adverse events. First, the lowest effective dose of medication should be used. Second, a practice of initiating medication at a low dose and titrating upward gradually is wise. Third, polypharmacy should be avoided whenever possible and the possibility of drug–drug interactions should be carefully considered if medications must be combined. Finally, the clinician should use existing knowledge to reduce the risk of adverse effects in vulnerable populations (e.g., choosing the antidepressant least likely to lower seizure threshold for a child with epilepsy).37

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 17, 2016 | Posted by in PSYCHOLOGY | Comments Off on Treating Depression in Children and Adolescents With Chronic Physical Illness

Full access? Get Clinical Tree

Get Clinical Tree app for offline access